7192
G. Occhipinti et al. / Tetrahedron 65 (2009) 7186–7194
ethyl acetate, to obtain target product 1-(2,4,6-trimethylphenyl)-
(complex 5) as well the orange fraction (complex 6) were collected
and concentrated and afforded 43 mg (40.2%) and 3.2 mg (2.8%),
respectively.
1H-imidazole in a yield of 69.7%.
Mp¼112–114 ꢀC; 1H NMR (CDCl3, 400 MHz):
¼7.43 (m, 1H),
d
7.23 (m, 1H), 6.97 (m, 2H), 6.89 (m, 1H), 2.34 (s, 3H), 1.99 (s, 6H); 13C
Mp 190–192 ꢀC (dec); 1H NMR (CD2Cl2, 500 MHz):
d¼15.90 (s,
NMR55 (CDCl3, 400 MHz):
120.2, 21.1, 17.4; IR
[cmꢁ1]: 3114, 3094, 2970, 2954, 2921, 2860,
d¼138.9, 137.6, 135.6, 133.5, 129.7, 129.1,
1H), 8.21 (d, J¼3.0 Hz, 1H), 8.03 (dd, J¼9.2, 3.0 Hz, 1H), 7.97 (d,
J¼3.0 Hz, 1H), 7.71 (dd, J¼9.3, 3.0 Hz, 1H), 7.42–7.37 (m, 1H), 7.31 (d,
J¼13.6 Hz, 1H), 7.28 (d, J¼2.1 Hz, 1H), 7.21 (d, J¼1.9 Hz, 1H), 7.02 (s,
1H), 6.81–6.91 (m, 4H), 6.67 (d, J¼9.2 Hz, 1H), 6.60 (d, J¼2.1 Hz, 1H),
6.37 (d, J¼1.9 Hz,1H), 6.21 (s,1H), 6.08 (s,1H), 6.04 (d, J¼9.3 Hz,1H),
6.01 (d, J¼13.8 Hz, 1H), 5.78 (septet, J¼6.7 Hz, 1H), 4.50 (d,
J¼13.8 Hz, 1H), 4.40 (d, J¼13.6 Hz, 1H), 2.36 (s, 3H), 1.80 (s, 3H), 1.79
(s, 3H), 1.64 (d, J¼6.7 Hz, 3H), 1.56 (d, J¼6.7 Hz, 3H), 1.48 (s, 3H), 1.04
n
1642, 1594, 1499, 1465, 1446, 1379, 1314, 1284, 1237, 1112, 1097,
1068, 1035, 1017, 971, 937, 907, 871, 816, 783, 737, 671.
4.1.2. 3-(2-Hydroxy-5-nitrobenzyl)-1-(2,4,6-trimethylphenyl)
imidazolium bromide (2a)
1-(2,4,6-Trimethylphenyl)-1H-imidazole (0.61 g, 3.3 mmol) and
2-hydroxy-5-nitrobenzyl bromide (0.76 g, 3.3 mmol) was dissolved
in toluene (8 mL) and refluxed for 18 h. During the course of the
reaction, a pale yellow solid precipitated in the reaction mixture.
After the reaction mixture was cooled to room temperature, the
solid was isolated on a filter placed in a Bu¨chner funnel, washed
with methyl-tert-butyl ether (3ꢂ10 mL) and dried under vacuum to
obtain a yield of 98.5% (1.35 g). The imidazolium salt was succes-
sively crystallized by slow diffusion of diethyl ether into a concen-
trated solution of 2a in ethanol.
(s, 6H); 13C NMR (CD2Cl2, 125.8 MHz):
d¼297.9 (d, J¼9.8), 179.0,
177.7,176.4,173.1,154.5,146.0,140.0,138.6,136.9,136.3,135.3,135.2,
134.2, 133.6, 133.5, 130.1, 129.0, 128.9, 128.5, 127.7, 126.7, 126.5,
126.4, 125.9, 125.4, 125.2, 124.4, 123.6, 123.4, 121.9, 121.8, 120.4,
117.9, 77.8, 52.3, 51.2, 22.7, 21.9, 21.1, 20.9, 18.3, 17.5, 16.75, 16.66; IR
(film)3182, 3131, 2963, 2922, 2857, 1935, 1767, 1591, 1563, 1476,
1441, 1404, 1376, 1348, 1272, 1183, 1170, 1149, 1124, 1110, 1085, 1034,
1018, 965, 932, 836, 752, 710, 702, 686, 660 cmꢁ1. MS (EI) m/z: 922.
HRMS (ESIpos) m/z 923.270932 (MþH)þ; calcd for C48H49N6O7Ru:
923.272688.
Mp¼276–278 ꢀC (dec); 1H NMR ((CD3)2SO, 400 MHz):
¼11.83
d
(br, 1H), 9.59 (s, 1H), 8.39 (s, 1H), 8.21 (d, J¼8.6 Hz, 1H), 8.06 (s, 1H),
7.93 (s, 1H), 7.20–7.07 (m, 3H), 5.56 (s, 2H), 2.32 (s, 3H), 2.01 (s, 6H);
4.1.5. Complex 6
13C NMR ((CD3)2SO, 400 MHz):
d
¼162.4, 140.3, 139.4, 138.2, 134.3,
131.2, 129.2, 127.1, 126.9, 124.1, 123.3, 121.4, 115.9, 48.3, 20.6, 16.9; IR
[cmꢁ1]: 3161, 3067, 2943, 1617, 1593, 1567, 1549, 1524, 1495, 1437,
Hoveyda first generation catalyst (135 mg, 2.25ꢂ10ꢁ4 mol) and
silver complex 4a (200 mg, 4.45ꢂ10ꢁ4 mol) were transferred to
a 25 mL Schlenk flask. The flask was evacuated and back filled with
argon. Then 6 mL of dry THF were added to the Schlenk flask under
argon. The mixture was stirred at reflux for 7 h, the mixture cooled
to room temperature and the solvent removed under reduced
pressure. The residue, a dark-brown solid was passed through
a silica gel column using diethyl ether/hexanes (7:3) as eluent. The
green fraction (complex 5) as well as the orange fraction (complex 6)
were collected and concentrated and afforded, respectively,13.2 mg
(6.3%) and 25.5 mg (11.9%).
n
1388, 1340, 1281, 1197, 1154, 1133, 1118, 1092, 1068, 935, 925, 897,
856, 843, 831, 820, 790, 770, 753, 747, 732, 700, 664; MS (ESI): m/z:
338 [417ꢁBr]þ. Anal. Calcd for C19H20N3O3Br: C, 54.56; H, 4.82; N,
10.05; Found: C, 54.84; H, 4.76; N, 9.88.
4.1.3. Synthesis of the silver complex (4a)
3-(2-Hydroxy-5-nitrobenzyl)-1-(2,4,6-trimethylphenyl) imida-
zolium bromide (500 mg, 1.195ꢂ10ꢁ3 mol) and silver (I) oxide
(569.4 mg, 2.457ꢂ10ꢁ3 mol) were added to a round bottom flask
Mp 193–195 ꢀC (dec); 1H NMR (CD2Cl2, 500 MHz):
d¼8.05–8.00
equipped with
a
cooler. Then, dried THF and benzene
(m, 2H), 7.83 (d, J¼2.9 Hz, 1H), 7.79 (dd, J¼9.1, 2.9 Hz, 1H), 7.25 (ddd,
J¼8.5, 7.3, 1.8 Hz, 1H), 7.20 (d, J¼2.0 Hz, 1H), 6.99 (br s, 1H), 6.93 (d,
J¼2.0 Hz, 1H), 6.88 (br s, 1H), 6.75–6.69 (m, 2H), 6.55–6.59 (m, 2H),
6.47 (dd, J¼7.6, 1.8 Hz, 1H), 6.38 (d, J¼2.0 Hz, 1H), 6.34 (d, J¼9.1 Hz,
1H), 6.27 (td, J¼7.3, 0.8 Hz, 1H) 6.11 (d, J¼14.1 Hz, 1H), 5.56 (d,
J¼14.1 Hz, 1H), 4.55 (septet, J¼6.0 Hz, 1H), 4.48 (d, J¼14.1 Hz, 1H),
3.80 (d, J¼14.1 Hz, 1H), 2.35 (s, 3H), 2.16 (s, 6H), 1.85 (s, 3H), 1.59 (s,
3H), 1.47 (s, 3H), 1.37 (d, J¼6.0 Hz, 3H), 1.22 (d, J¼6.0 Hz, 3H); 13C
(8.5 mLþ8.5 mL), and molecular sieves 4 Å (1.115 g) were added. The
reaction mixture was stirred at reflux for 3 h, cooled to room tem-
perature and diluted with CH2Cl2 (80 mL). The mixture was then fil-
tered through a pad of Celite (2/5 cm, w/l), that was thenwashed with
CH2Cl2 (3ꢂ20 mL). The solvent was removed under reduced pressure
to provide a yellow solid, the silver complex in a yield of z65%
(342.5 mg).
Mp 178–180 ꢀC (dec); 1H NMR (CDCl3, 600 MHz):
d
¼8.14 (s, 1H),
NMR (CD2Cl2, 125.8 MHz):
d¼244.3, 179.9, 172.8, 171.5, 161.6, 149.1,
7.76 (d, J¼7.9 Hz, 1H), 7.36 (s, 1H), 7.00 (s, 2H), 6.96 (s, 1H), 5.80 (d,
145.6, 140.2, 138.7, 138.3, 138.2, 137.7, 135.0, 134.5, 134.3, 133.9,
130.7, 130.5, 129.7, 129.2, 129.1, 128.9, 127.9, 127.0, 126.2, 126.1,
125.6,125.0,124.9,123.1,123.0,121.8,121.7,120.8,120.6,120.5,111.3,
70.0, 52.2, 49.4, 22.8, 22.1, 21.1, 20.9, 19.0, 18.6, 18.3, 16.8; IR
(film)3165, 3126, 3098, 3064, 2963, 2923, 2845, 1593, 1564, 1472,
1439, 1404, 1382, 1278, 1258, 1172, 1153, 1121, 1087, 1016, 957, 932,
903, 867, 837, 792, 751, 732, 710, 697, 666 cmꢁ1. MS (EI) m/z: 956.
J¼7.9 Hz, 1H), 5.23 (s, 2H), 2.39 (s, 3H), 1.93 (s, 6H). 13C NMR (CDCl3,
500 MHz)56
124.4, 122.0, 121.7, 121.3, 50.7, 21.3, 18.0; IR
:
d
¼174.6, 139.7, 136.4, 135.2, 134.6, 129.3, 127.5, 127.0,
n n: 3127,
[cmꢁ1]: IR
2920,1589,1566,1469,1437,1408,1278,1253,1237,1188,1165,1151,
1085, 1031, 927, 854, 835, 820, 790, 768, 735, 706, 679, 652; Anal.
Calcd for C76H72O12N12Ag4: C, 51.37; H, 4.08; N, 9.46. Found: C,
50.49; H, 3.81; N, 8.92.
HRMS
(ESIpos)
m/z
957.231375
(MþH)þ;
calcd
for
C48H48ClN6O7Ru: 957.232952.
4.1.4. Complex 5
70 mg (1.17ꢂ10ꢁ4 mol) of Hoveyda first generation catalyst and
58 mg (1.31ꢂ10ꢁ4 mol) of silver complex 4a were added to a 25 mL
Schlenk flask. The flask was evacuated and back filled with argon.
Then 2.5 mL of dry toluene and 2.5 mL of dry THF were added to the
Schlenk flask under argon. The mixture was stirred at 55 ꢀC for
2.5 h, a further 46 mg of silver complex (1.03ꢂ10ꢁ4 mol) then
added and the reaction was continued at the same temperature for
another 2.5 h, after which the mixture was cooled to room tem-
perature and the solvent removed under reduced pressure. The
residue, a dark-brown solid was passed through a silica gel column
using diethyl ether/hexanes (9:1) as eluent. The green fraction
4.1.6. NMR Spectroscopy
Sample preparation: A sample of the Ru-complex 6 (z5 mg) was
transferred to a NMR tube (o.d. 5 mm, Wilmad, model 528-PP-7) and
dissolved in dichloromethane-d2.
High-resolution one-dimensional and two-dimensional 1H
(600.13 MHz) and 13C (150.91 MHz) NMR spectra were acquired on
a Bruker Biospin AVANCE AV600 spectrometer equipped with
a narrow bore UltraShieldÔ Plus magnet. A 5 mm inverse triple
resonance (1H, 13C, 15N) CryoProbe with a z-gradient coil and cryo-
genic preamplifier cooling for both the 1H and 13C channels was
used. 1D 1H NMR: The spectral width was 7184 Hz, the pulse width